Biad, Porferio B.
HRN: 25-53-63 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2024
CEFUROXIME 1.5GM (VIAL)
12/03/2024
12/10/2024
IV
1.5gm
1 Hour PTOR Then Q8
Nasomaxillary Mass
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes